MEGESIN 160mg tablets medication leaflet

L02AB01 megestrol • Antineoplastic and immunomodulating agents | Hormones and related agents | Progestogens

Megestrol is a medication primarily used to treat breast cancer and endometrial cancer. It is also used to stimulate appetite and prevent weight loss in patients with chronic illnesses such as AIDS or advanced cancer.

This drug belongs to the class of progestins and works by altering hormonal balance, inhibiting the growth of hormone-sensitive cancer cells. Additionally, megestrol can help increase body mass by stimulating appetite.

Megestrol is available in tablet or oral suspension form, and the dosage is adjusted based on the condition being treated and the patient's response. Treatment may have side effects such as weight gain, fluid retention, mood changes, or gastrointestinal disturbances.

Patients taking megestrol should be regularly monitored by their doctor, especially if they have a history of thrombosis or other cardiovascular conditions. Pregnant or breastfeeding women should not use this medication.

General data about MEGESIN 160mg

Substance: megestrol

Date of last drug list: 01-06-2025

Commercial code: W52184001

Concentration: 160mg

Pharmaceutical form: tablets

Quantity: 30

Product type: generic

Price: 121.16 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: S.C. SINDAN S.R.L. - ROMANIA

Holder: TEVA B.V. - OLANDA

Number: 11544/2019/01

Shelf life: 5 years

Pharmaceutical forms available for megestrol

Concentrations available for megestrol

160mg, 40mg, 40mg/ml

Other substances similar to megestrol

Compensation lists for MEGESIN 160mg ACTAVIS

NHP 3 (C2) - NHP oncology

Price

Copayment

Patient

121.16 RON

121.16 RON

0.00 RON